Canopy Growth Corp Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Canopy Growth Corp share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- Canopy Growth Corp share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-12-31 was 274.00 shares.
- Canopy Growth Corp share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-03-31 was 500.00 shares.
- Canopy Growth Corp share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-12-31 was -5.79K shares.
- Canopy Growth Corp share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 18.62K shares, a 1529.13% increase from fiscal 2024.
- Canopy Growth Corp share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 1.14K shares, a 85.64% decline from fiscal 2023.
- Canopy Growth Corp share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 7.96K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-15 | 18.62K shares 10-K · filed 2026-06-15 |
| 2024-12-31 | 274.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-07 | |
| 2024-03-31 | 500.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-15 | 1.14K shares 10-K · filed 2026-06-15 |
| 2023-12-31 | -5.79K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-09 | |
| 2023-03-31 | -68.97K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-30 | 7.96K shares 10-K · filed 2025-05-30 |
| 2022-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-09 | |
| 2022-09-30 | 22.36K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-09 | |
| 2022-06-30 | 54.57K shares 10-Q · filed 2022-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |